Healthcare Biomarkers Market Report Reviews Drivers, Analysis, Share, Growth, Trends & Forecast to 2026

The MarketWatch News Department was not involved in the creation of this content.

Sep 14, 2020 (Heraldkeepers) —
The Global Healthcare Biomarkers Market is expected to exceed more than US$ 56 billion by 2022 and will grow at a CAGR of more than 13% in the given forecast period.

FYI, You will get latest updated report as per the COVID-19 Impact on this industry. Our updated reports will now feature detailed analysis that will help you make critical decisions.

The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Roche Diagnostics Ltd., Abbott Laboratories, Inc., Agilent Technologies, Inc., Epigenomics AG, GE Healthcare, Johnson & Johnson, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Siemens Healthcare GmbH, Qiagen N.V., and Merck& Co., Inc. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.

A biomarker refers to a biological molecule or gene that is used to efficiently and correctly evaluate pharmacologic responses, pathogenic approaches, and biological tactics. Also known as a molecular marker or signature molecule, biomarkers are located in blood, different frame fluids, and tissue. Drastically used to peer the frame’s response to a selected remedy for a disease or condition, biomarkers assist clinical specialists to take powerful clinical decisions and help in diagnosing the fitness of patients. The U.S. food and drug management has approved the usage of biomarkers as surrogate quit-factors in the remedy improvement process. Biomarkers play a pivotal role in ailment danger assessment, drug discovery and improvement, diagnostics improvement, personalized medicinal drug, and others. Research activities are especially focused on the development of diagnostics biomarkers for most cancers.

You Can Find Full Report @:

The major driving factors of Global Healthcare Biomarkers Market are as follows:
? Rise in number of cros and low down cost for conduct clinical trials in developing nations.
? Use of biomarkers in diagnostic procedure is enhancing rapidly.
? Increasing healthcare expenses and R&D funding.

The restraining factors of Global Healthcare Biomarkers Market are as follows:
? Technological issue associated to sample and storage.
? High investment and low cost and benefit ratio.
? High testing cost

The Global Healthcare Biomarkers Market is segmented on the lines of its product, type, application, disease indication and regional. Based on product segmentation it covers consumable, software and services. Type segmentation covers safety biomarker, validation biomarker and efficacy biomarker. The applications segmentation contains diagnostics development, personalized medicine, drug discovery & development and disease risk assessment. Under disease indication segmentation it covers cancer, neurological disorders, cardiovascular disorders and immunological disorders. The Global Healthcare Biomarkers Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.

This report provides:
1) An overview of the global market for Healthcare Biomarkers and related technologies.
2) Analyses of global market trends, with data from 2013, estimates for 2014 and 2015, and projections of compound annual growth rates (CAGRs) through 2022.
3) Identifications of new market opportunities and targeted promotional plans for Healthcare Biomarkers.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.


The scope of the report includes a detailed study of global and regional markets for Global Healthcare Biomarkers Market with the reasons given for variations in the growth of the industry in certain regions.

The GlobalHealthcare Biomarkers Market has been segmented as below:

The Global Healthcare Biomarkers Market is Segmented on the lines of Product Analysis, Type Analysis, Application Analysis, Disease indication Analysis and Regional Analysis. By Product Analysis this market is segmented on the basis of Consumable, Software and Services. By Type Analysis this market is segmented on the basis of Safety biomarker, Validation biomarker and Efficacy biomarker.

By Application Analysis this market is segmented on the basis of Diagnostics development, Personalized medicine, Drug discovery & development and Disease risk assessment. By Disease indication Analysis this market is segmented on the basis of Cancer, Neurological disorders,
Cardiovascular disorders and Immunological disorders. By Regional Analysis this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the World.

Request Sample Report:

Table of Contents

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Biomarkers Market, By Product

7 Biomarkers Market, By Type

8 Biomarkers Market, By Application

9 Biomarkers Market, By Disease Indication

10 Biomarkers Market, By Region

11 Competitive Landscape

12 Company Profiles

12.1 Qiagen N.V.

12.2 Perkinelmer, Inc.

12.3 Merck Millipore

12.4 Bio-Rad Laboratories, Inc.

12.5 Enzo Biochem, Inc.

12.6 EKF Diagnostics Holdings, Inc.

12.7 Meso Scale Diagnostics, LLC.

12.8 Biosims Technologies Sas

12.9 Cisbio Bioassays

12.10 Signosis, Inc.

Other Related Market Research Reports:

Healthcare Life Sciences & Analytical Reagents Market Share will Increase US$ 10.00 Billion By 2024

High Potency API and HPAPI Market is Anticipated to Grow US$ 24 Billion By 2024

Human Insulin Drugs & Delivery Devices Market is Expected to Grow US$ 45 Billion By 2022

Media Contact

Company Name: Market Research Engine

Contact Person: John Bay

Email: [email protected]

Phone: +1-855-984-1862

Country: United States



Is there a problem with this press release? Contact the source provider Comtex at [email protected] You can also contact MarketWatch Customer Service via our Customer Center.

The MarketWatch News Department was not involved in the creation of this content.

Next Post

Spirent Automation Helps Leading Malaysia Telecommunication Provider Speed Up Product Development

Wed Sep 16 , 2020
Lab as a Service solution dramatically reduces testbed setup time from days to minutes Spirent Communications plc (LSE:SPT), a leading provider of test, assurance, and analytics solutions for next-generation devices and networks, today announced the successful deployment of its Velocity Lab as a Service (LaaS) solution by a leading telecommunication […]
Spirent Automation Helps Leading Malaysia Telecommunication Provider Speed Up Product Development

You May Like